Biomarker-Based Risk Score May Predict Heart Failure in Type 2 Diabetes
A biomarker-based risk score to predict hospitalization for heart failure (HHF) among patients with type 2 diabetes (T2D) was able to identify patients at an increased risk
A biomarker-based risk score to predict hospitalization for heart failure (HHF) among patients with type 2 diabetes (T2D) was able to identify patients at an increased risk
Rivaroxaban, compared with dabigatran or apixaban, was found to be associated with increased rates of gastrointestinal (GI) bleeding, according to study findings published in the Annals
The growth of transcatheter aortic valve replacement (TAVR) in 2012 to 2018 mainly occurred in hospitals in metropolitan areas, according to a study published online
Glucagon-like peptide-1 receptor agonists (GLP-1RAs) such as semaglutide and liraglutide may hold potential in the management of nonalcoholic fatty liver disease (NAFLD), given their observed
Treatment with enzyme-inducing antiseizure medications (eiASMs) may be associated with a higher risk of incident cardiovascular disease (CVD) among adult patients with epilepsy, according to
Chronic kidney disease (CKD) and atrial fibrillation (AF) are both risk factors for bleeding, stroke and mortality. Whether the combination of CKD and AF leads